ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 997,32
-0,75%
Dow Jones
38 852,86
-0,55%
DAX
18 576,40
-0,58%
Brent Oil
84,63
0,36%
Bitcoin
67 690,49
-0,88%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ImmuCell Corporation (ICCC)

  7. ImmuCell Corporation (ICCC) Actualités

ICCC

ImmuCell (ICCC)

ImmuCell Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ICCC
DateHeureSourceTitreSymboleSociété
22/05/202422h50Edgar (US Regulatory)Form SCHEDULE 13D - General statement of acquisition of beneficial ownershipNASDAQ:ICCCImmuCell Corporation
14/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
14/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
14/05/202422h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
08/05/202419h00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
09/04/202422h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024NASDAQ:ICCCImmuCell Corporation
27/02/202422h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
16/02/202415h30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
08/01/202422h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023NASDAQ:ICCCImmuCell Corporation
13/11/202322h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
07/11/202318h15GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
05/10/202322h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023NASDAQ:ICCCImmuCell Corporation
06/09/202318h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
29/08/202314h00GlobeNewswire Inc.ImmuCell Announces Submission of CMC Technical Section to the FDANASDAQ:ICCCImmuCell Corporation
10/08/202322h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
07/08/202318h00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
13/07/202320h28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ICCCImmuCell Corporation
11/07/202322h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023NASDAQ:ICCCImmuCell Corporation
29/06/202319h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ICCCImmuCell Corporation
28/06/202322h05GlobeNewswire Inc.ImmuCell Announces Change in Timing of Anticipated FDA SubmissionNASDAQ:ICCCImmuCell Corporation
21/06/202322h05GlobeNewswire Inc.ImmuCell Appoints Bryan K. Gathagan to Board of DirectorsNASDAQ:ICCCImmuCell Corporation
15/06/202322h05GlobeNewswire Inc.ImmuCell Announces Approval of Principal Terms of a $3 Million Debt FacilityNASDAQ:ICCCImmuCell Corporation
16/05/202315h00GlobeNewswire Inc.ImmuCell to Hold Virtual-Only Annual Meeting of StockholdersNASDAQ:ICCCImmuCell Corporation
11/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ICCCImmuCell Corporation
11/05/202322h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
04/05/202312h30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
28/04/202316h18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ICCCImmuCell Corporation
28/04/202316h14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ICCCImmuCell Corporation
18/04/202323h11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ICCCImmuCell Corporation
05/04/202322h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023NASDAQ:ICCCImmuCell Corporation
 Showing the most relevant articles for your search:NASDAQ:ICCC

Dernières Valeurs Consultées

EU
EN
Bouygues
EU
DG
Vinci
EU
SGO
Cie de SaintGobain
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
EU
BEL20
Bel 20
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
FTSE
UKX
FTSE 100
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés